The Medical Minute – Ep. #73 – ASCO Direct™: A Patient Perspective FT. Dr. Alex Adjei
CCA’s Steve Abbott and Dr. Abdul Jazieh welcome Dr. Alex Adjei to discuss the overall survival analysis from the ADAURA trial of adjuvant osimertinib in pati…
Related Articles
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR)
ABSTRACTIntroduction. Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North…
Quality Measures for Multidisciplinary Tumor Boards and Their Role in Improving Cancer Care
ABSTRACTIntroduction. While multidisciplinary tumor boards (MTBs) are widely used in managing patients with cancer, their impact on patient care and outcome is not routinely measured…
Quality Measures for Multidisciplinary Tumor Boards and Their Role in Improving Cancer Care
ABSTRACTIntroduction. While multidisciplinary tumor boards (MTBs) are widely used in managing patients with cancer, their impact on patient care and outcome is not routinely measured…
Should Oncologists Continue to Be Ambivalent About Dietary Supplement
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
